Background. Calciphylaxis is a rare, painful, life-threatening problem of cutaneous necrosis and refractory healing in patients with uremia and secondary hyperparathyroidism. The pathogenesis involves abnormalities in calcium and phosphorus metabolism and acute deposition of calcium in tissues. Method. The clinical course of 16 patients who were diagnosed with calciphylaxis at our institution from 1994 through 1998 was reviewed. Results. Fourteen female patients and 2 male patients had chronic renal disease, secondary hyperparathyroidism, and characteristic skin necrosis (mean age, 56 years; range, 39-70 years). All patients underwent intensive medical therapy, including ongoing hemodialysis (n = 16 patients), parathyroidectomy (n = 7 patients), and debridement of cutaneous lesions (n = 8 patients). Mean serum values in surgical and nonsurgical patients were significantly different for phosphorus, calcium-phosphorus product, and parathormone levels. Median survival was 9.4 months; 15 patients (93%) have died. The median survival time for parathyroidectomy versus nonparathyroidectomy was 14.8 and 6.3 months (P =.22), for skin debridement versus nondebridement was 14.1 and 6.1 months (P =.08), and for diabetic versus nondiabetic patients was 6.5 and 13.9 months (P =.11). Conclusions. Calciphylaxis has a female preponderance, with a dismal prognosis. A multidisciplinary approach that uses frequent hemodialysis to normalize calcium and phosphorus levels and local debridement of skin lesions seems prudent. Parathyroidectomy cannot be recommended routinely in all patients, unless severe hyperparathyroidism mandates intervention. (Surgery 2000;128:967-72.)
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Systemic calciphylaxis.Intern Med. 1995; 34: 822-823
- Calciphylaxis in chronic renal failure.J Am Soc Nephrol. 1996; 7: 978-982
- Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure.Vasa. 1998; 27: 137-143
- The uremic gangrene syndrome: improved healing in spontaneously forming wounds following subtotal parathyroidectomy.Plast Reconstr Surg. 1996; 98: 671-678
- Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis.Am J Med. 1990; 88: 252-257
- Calciphylaxis.: University of Chicago Press, Chicago, Ill1962
- Sensitization to calciphylaxis by endogenous parathyroid hormone.Endocrinology. 1962; 71: 554-558
- Calciphylaxis in patients on hemodialysis: a prevalence study.Surgery. 1997; 122: 1083-1089
- Calcifying panniculitis associated with polycystic kidney disease and chronic renal failure.J Am Acad Dermatol. 1990; 22: 743-747
- Calciphylaxis: case report and treatment review.Cutis. 1999; 63: 149-153
- Calciphylaxis: early recognition and management.Am Surg. 1994; 60: 81-86
- Calciphylaxis in secondary hyperparathyroidism.Arch Surg. 1991; 126: 1213-1219
- Calciphylaxis in three patients with end-stage renal disease.Arch Dermatol. 1995; 131: 63-68
*Reprint requests: David R. Farley, MD, Division of Gastroenterologic and General Surgery, Mayo Clinic, 200 Second St SW, Rochester, MN 55905.
© 2000 Mosby, Inc. Published by Elsevier Inc. All rights reserved.